Orthobond™ is an innovative company specializing in antimicrobial technology, particularly through the development of proprietary antimicrobial nanosurfaces. These nanosurfaces are designed to be permanently bound to various materials, effectively killing bacteria, viruses, and fungi by mechanically disrupting their structures, rather than relying on traditional antibiotics. Their flagship product, Ostaguard™, is an antibacterial treatment that can be applied to existing implantable medical devices, providing a robust defense against microbial contamination that often leads to complications in orthopedic procedures. Orthobond's technology is not only applicable in the medical field but also extends to commercial, industrial, and automotive sectors, showcasing its versatility and potential for widespread impact.

The company’s approach addresses a critical need in the medical device industry, where infections related to implants are a growing concern, particularly with the rise of antibiotic-resistant bacteria. Orthobond's surface treatments are non-eluting and do not involve antibiotics, significantly reducing the risk of developing drug-resistant strains. Their technology has been rigorously tested, demonstrating effectiveness against a wide range of pathogens commonly associated with device infections. With a focus on safety and biocompatibility, Orthobond aims to revolutionize infection control in medical devices and beyond, positioning itself as a leader in antimicrobial solutions.

United States

Orthobond is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces, with broad applications in the medical device industry and more such as commercial, industrial, automotive, and beyond. We’re the first company to utilize nanoscale surface modifications that can be permanently bound to any surface, killing bacteria, viruses, and fungi by mechanically rupturing pathogens without using antibiotics.

Orthobond

Company Details